Modeling Drug Resistance in a Conjoint Normal-Tumor Setting

Theoretical Biology and Medical Modelling - United Kingdom
doi 10.1186/1742-4682-12-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EMT, CTCs and CSCs in Tumor Relapse and Drug-Resistance

Oncotarget
Oncology
2015English

Modeling Microbial Drug-Resistance: From Mathematics to Pharmacoeconomics

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
2018English

A Convex Optimization Approach to Modeling Consumer Heterogeneity in Conjoint Estimation

Marketing Science
MarketingEconomicsInternational ManagementBusinessEconometrics
2007English

Additive Conjoint Measurement and the Resistance Toward Falsifiability in Psychology

Frontiers in Psychology
Psychology
2013English

Multi-Drug Loaded Vitamin E-TPGS Nanoparticles for Synergistic Drug Delivery to Overcome Drug Resistance in Tumor Treatment

Science Bulletin
Multidisciplinary
2016English

Modeling Hierarchical Conjoint Processes With Integrated Choice Experiments

Journal of Marketing Research
MarketingEconomicsInternational ManagementBusinessEconometrics
1994English

Application of Concave Microwells to Pancreatic Tumor Spheroids Enabling Anticancer Drug Evaluation in a Clinically Relevant Drug Resistance Model

PLoS ONE
Multidisciplinary
2013English

Drug Resistance From Preferred Antiretroviral Regimens for HIV Infection in South Africa: A Modeling Study

PLoS ONE
Multidisciplinary
2019English

Therapeutically Targeting Tumor Microenvironment–mediated Drug Resistance in Estrogen Receptor–positive Breast Cancer

Journal of Experimental Medicine
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy